Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Boc-Gamma-Abu-OH

    • Product Name Boc-Gamma-Abu-OH
    • Alias Boc-Gamma-aminobutyric acid
    • Einecs 245-877-9
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    907463

    Product Name Boc-Gamma-Abu-OH
    Synonym Boc-4-Aminobutyric acid
    Cas Number 119615-63-1
    Molecular Formula C9H17NO4
    Molecular Weight 203.24
    Appearance White to off-white solid
    Purity Typically ≥98%
    Storage Temperature 2-8°C
    Protecting Group Boc (tert-butoxycarbonyl)
    Smiles CC(C)(C)OC(=O)NCCCC(=O)O

    As an accredited Boc-Gamma-Abu-OH factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Boc-Gamma-Abu-OH is supplied in a 5g sealed amber glass bottle, labeled with product details, handling, and safety information.
    Shipping Boc-Gamma-Abu-OH is shipped in secure, airtight containers to ensure product stability and prevent contamination. The chemical is typically dispatched at ambient temperature unless otherwise specified, with clear hazard labeling if required. Handling and transport comply with relevant chemical safety regulations to guarantee safe and timely delivery.
    Storage **Boc-Gamma-Abu-OH** should be stored in a tightly sealed container in a cool, dry place, protected from light and moisture. Ideally, keep it at 2–8°C (refrigerator temperature) and away from incompatible substances such as strong acids or bases. Ensure proper labeling and limit exposure to air to prevent degradation. Handle under suitable laboratory conditions to maintain stability.
    Application of Boc-Gamma-Abu-OH

    Applications of Boc-Gamma-Abu-OH in Industrial Manufacturing

    Boc-Gamma-Abu-OH serves as a critical protected amino acid intermediate in high-value, quality-driven specialty manufacturing. Its stable carbamate protection and gamma-aminobutyric acid structure underpin essential processes in peptide synthesis, pharmaceutical ingredient development, and biotechnological innovation. Below, we detail its principal downstream industrial applications and integration points for OEM, CDMO, and institutional buyers.

    1. Active Pharmaceutical Ingredient (API) Peptide Synthesis

    Peptide-based pharmaceuticals rely heavily on protected amino acid derivatives for precise stepwise assembly and high-purity end products. Boc-Gamma-Abu-OH introduces a protected gamma-aminobutyric acid segment during solid-phase or solution-phase peptide coupling, critical for proprietary and generic drug peptide blocks, including neuropeptide analogs, hormonal APIs, and antimicrobial peptides. Its defined protection group ensures minimal racemization and base-labile deprotection compatible with cGMP manufacturing flow.

    Industry compliance standards

    • ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
    • United States Pharmacopeia (USP) General Chapter <1285> Peptide and Oligonucleotide Drugs
    • European Pharmacopoeia (Ph. Eur.) 2.9.40 Amino acid analysis
    • FDA 21 CFR Part 210/211 (Finished Pharmaceuticals GMP)

    Typical usage ratio

    • 0.9 to 1.1 molar equivalents per amino acid residue, adjusted to minimize over-coupling and side-reactions based on resin loading, scale, and targeted sequence length

    Downstream process integration

    • Introduced during solid-phase peptide synthesis (SPPS) cycles after initial resin functionalization and elongation, or as a protected γ-amino acid in solution-phase multi-step peptide building.

    Final product types

    • Injectable peptide APIs (synthetic vasopressin analogs, somatostatin analogs)
    • Oral peptide hormone therapeutics
    • Antimicrobial peptide intermediates
    • Specialty oligopeptides for rare disease therapies

    2. Biopharmaceutical Research Reagent Manufacturing

    Research toolkits for cell signaling, GABAergic pathway modeling, and protein engineering often require specialty peptide and amino acid derivatives. Boc-Gamma-Abu-OH supports precise site-directed mutagenesis, structure-activity relationship assays, and the supply of defined-length peptidomimetics in industrial life science reagent manufacturing environments. Its protection is compatible with diverse deprotection schemes in automated bioprocessing and analog library generation for screening platforms.

    Industry compliance standards

    • ISO 13485 (Medical Device and Diagnostic Quality Systems)
    • ISO 9001:2015 (Quality Management Systems)
    • OECD Principles of Good Laboratory Practice (GLP)
    • REACH Annex IV (Substances Exempt from Registration when used as research chemicals)

    Typical usage ratio

    • 1.0 eq per resin loading site or target peptide coupling site, optimized based on intended peptide analog sequence and synthesis protocol

    Downstream process integration

    • Dosed into robotic peptide synthesizer feed tanks or solution-phase batch reactors after initial deprotection and washing; post-reaction, followed by TFA-based global deprotection for purifying target analogs

    Final product types

    • Synthetic peptide standards for calibration and quantification
    • Custom research peptides for neurobiology and immunology
    • Labeled and non-labeled gamma-aminobutyric acid derivatives
    • High-purity library peptides for structure-activity screening

    3. Cosmetic Bioactive Peptide Production

    Cosmeceutical and dermal formulation manufacturers source protected amino acids to enable the scalable assembly of bioactive pentapeptides, hexapeptides, and skin-rejuvenating peptide fragments. Using Boc-Gamma-Abu-OH, formulators achieve precise incorporation of GABA analog elements essential for neuro-calming active ingredients aimed at anti-wrinkle, skin-firming, and moisturizing applications. The stability of Boc protection improves batch-to-batch reproducibility across GMP-compliant cosmetic peptide workshops.

    Industry compliance standards

    • ISO 22716 (Cosmetic GMP)
    • EU Regulation (EC) No 1223/2009 on Cosmetic Products
    • China NMPA Cosmetic Peptide Ingredient Guidelines
    • REACH Regulation (EC) No 1907/2006 for cosmetic ingredients

    Typical usage ratio

    • 0.95–1.05 equivalents per peptide active fragment, adjustable depending on chain length and degree of functionalization required

    Downstream process integration

    • Utilized at the protected amino acid addition stage for automatic or manual solid-phase peptide assembly, especially in the production of GABA-mimetic or skin bioactive peptide classes; followed by acid- or hydrogenolysis-based deprotection before downstream purification

    Final product types

    • Peptide-based anti-aging serums and creams
    • Bioactive peptides for skin barrier enhancement
    • GABA-modulated neuro-calming cosmetic actives
    • Hydrolyzed peptide complexes for topical formulations

    4. Pharmaceutical Intermediate for CNS Drug Development

    Finished dosage manufacturers developing CNS-related small molecule APIs rely on protected gamma-amino butyric acid fragments introduced at key steps in the synthetic route. Boc-Gamma-Abu-OH supports the assembly of CNS-targeted prodrugs, GABAergic ligands, and related intermediates. The compound’s protection chemistry ensures compatibility with multi-step N-alkylation, acylation, and cyclization used in advanced CNS pipeline molecule construction.

    Industry compliance standards

    • cGMP Certification under US FDA 21 CFR Part 211 for intermediates and APIs
    • Japanese Pharmacopoeia (JP) for CNS-related drug substances
    • Drug Master File (DMF) submission for novel CNS intermediates
    • ICH Q3A/B (Impurities in New Chemical Entities and APIs)

    Typical usage ratio

    • 1.0–1.2 eq per coupling, varying with stage of GABA motif introduction and purity requirements at each synthetic node

    Downstream process integration

    • Added after initial core ring assembly or during chain elongation to introduce GABA-protected functionalities, followed by selective deprotection and coupling with CNS-active scaffolds prior to final salt formation or crystallization

    Final product types

    • Precursor intermediates for antiepileptic drugs
    • GABA analog CNS-active drug substances
    • GABA-prodrug intermediates for extended-release formulations
    • Carbamate-protected GABA building blocks for combinatorial CNS drug libraries

    5. Custom Peptidomimetic Library Synthesis

    Fine chemical synthesis laboratories and custom API developers use Boc-Gamma-Abu-OH for the creation of peptidomimetic scaffolds, foldamers, and analog libraries necessary for medicinal chemistry optimization and hit-to-lead screening. Its well-defined protection group is crucial for iterative synthesis cycles, enabling selective γ-amino acid insertion in multi-kilogram library production workflows, supporting structure optimization under industrial QC control.

    Industry compliance standards

    • ISO 9001:2015 (Quality Management Systems for chemical manufacturing)
    • OECD GLP compliance for regulated chemical library synthesis
    • REACH (EC) No 1907/2006 for research and industrial peptidomimetic chemicals
    • GMP principles for chemicals targeting clinical evaluation

    Typical usage ratio

    • 1.0 eq per target insertion site, adjusted by parallel synthesis protocol, library complexity, or purity control levels required

    Downstream process integration

    • Charged into solution-phase or automated parallel synthesizer systems at the γ-amino acid coupling stage; compatibility with Fmoc/t-Boc orthogonal protection strategies enables diverse sequence exploration for foldamer and peptidomimetic library development

    Final product types

    • Peptidomimetic lead candidates for medicinal chemistry
    • γ-Aminobutyric acid-rich foldamers for structural biology
    • Test compounds for hit-to-lead CNS library campaigns
    • Bioorthogonal labeling reagents based on gamma-aminobutyric acid cores
    Free Quote

    Competitive Boc-Gamma-Abu-OH prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Boc-Gamma-Abu-OH: A Reliable Building Block for Modern Peptide Synthesis

    Understanding Boc-Gamma-Abu-OH

    Boc-Gamma-Abu-OH makes peptide assembly a lot more straightforward for chemists who manage synthesis at scale. From experience working up close with its production, it’s clear this compound offers a distinctive balance between reactivity and stability. Many peptide research projects reach a point where the quality or readiness of an amino acid derivative makes or breaks the outcome. Boc-Gamma-Abu-OH often finds its place in those critical steps. Our staff manages each batch starting from sourcing high-purity raw materials and strictly controlling moisture and byproduct content, all because the process reflects directly in the yield and purity peptide researchers can expect.

    A lot of chemists first start using Boc-protected gamma-aminobutyric acid derivatives after running into issues with unwanted byproducts or side reactions with standard amino acid starters. Boc-Gamma-Abu-OH earns its keep especially for projects sensitive to impurities or cases where other derivatives don’t dissolve or react as predictably. The molecule features a bulky tert-butoxycarbonyl (Boc) group on the amino group, which helps shield it during peptide couplings, while freeing the carboxylic acid moiety for reliable attachment. We manufacture this compound as a free acid – not as a salt, not as an ester – precisely because this state delivers maximum flexibility for peptide bond formation, solid-phase synthesis, and fragment condensation.

    Specifications Matter to Daily Research

    Quality differences become apparent the moment you open a bottle. A fine, free-flowing powder indicates proper drying and precise crystallization, both of which keep your solvents clear and your coupling times predictable. We set strict moisture controls during every run: any excess water can rapidly hydrolyze the Boc group, spoiling an entire batch. From the earliest phase, we use chromatography and NMR methods to detect and rule out any side products or unprotected amino acid residues. Only material matching rigorous purity thresholds—typically above 98%—leaves our facility. We also produce Boc-Gamma-Abu-OH so it dissolves easily in common peptide synthesis solvents: DMF, DMSO, and acetonitrile all work without leaving sticky leftovers. Many labs complain about clumps or “caking” if materials aren’t processed and stored in the right conditions; such problems force extra filtration steps or re-crystallization. From our experience, tackling these issues in production, not afterward, gives researchers more time in synthesis and less fixing dissolved waste.

    Sometimes customers expect every Boc-protected amino acid to perform similarly, but our field teams have seen surprising differences. Boc-Gamma-Abu-OH retains much more shelf stability than unprotected gamma-aminobutyric acid; it holds up under refrigeration for months, with steady purity. Over decades, improvements in our own workflow have cut down trace metal contamination as well – copper and iron traces, common from older syntheses, now run below detection in our analysis. Even at high throughput, degradation by oxidative side reactions rarely shows up now, and that’s a function of tighter control starting from the earliest steps, right through final packaging under dry nitrogen.

    Application Insights from the Factory Floor

    In our operation, we see Boc-Gamma-Abu-OH leaving the warehouse for many uses beyond standard oligopeptide assembly. Industrial drug discovery programs push the demand for sequence-modified peptides, sometimes looking for gamma-amino substitutions where traditional alpha-series acids simply don’t fit. Our technical teams notice that many researchers rely on Boc-Gamma-Abu-OH because of its ability to introduce controlled flexibility, enhance water solubility, or reduce cleavage-induced epimerization. We’ve talked to process chemists struggling to build linkers or spacers that don’t cause steric congestion in solid-phase peptide synthesis. Customer feedback tells us that having a consistent Boc-Gamma-Abu-OH solid, with tight spec on both color and melting point, often prevents stubborn resin aggregations and resin-bead “gumming” witnessed with more hygroscopic analogues.

    Several years ago, our own pilot plant had to troubleshoot unexplained yield drops in a batch process due to different suppliers’ intermediates. It turned out that slight differences in the purification route—especially the order of distillation steps—directly affected how well Boc-Gamma-Abu-OH recrystallized. Analytical teams traced the problem to an overlooked trace byproduct: a branched isomer occasionally popping up when certain base catalysts lingered too long in purification. Only by adjusting timing and temperature did we hit the purity needed for critical pharmaceutical intermediates. Since then, we designed bespoke steps to always flush out isomers, relying on hands-on TLC and spectroscopic analysis at each phase. The effort pays back later in fewer “mysterious” HPLC peaks and easier regulatory documentation for our clients. The experience reinforces that you can’t cut corners in chemical manufacturing for such specialty building blocks.

    Comparing Boc-Gamma-Abu-OH with Other Options

    Chemists sometimes ask how Boc-Gamma-Abu-OH compares with Fmoc-protected varieties or with using unprotected gamma-amino acids in synthesis. Through years of manufacturing and user feedback, we see key differences that go beyond price tags or supplier datasheets. The Boc group, unlike Fmoc, removes cleanly under acidic conditions, allowing strategists to alternate protecting groups and avoid undesired cross-reactivity with bases. Fmoc groups serve well in some automation-friendly environments but require separate deprotection and waste-handling processes, particularly less attractive for high volumes where acidolysis stays safer and more straightforward.

    Boc-Gamma-Abu-OH displays more chemical inertia during storage and transport. The Boc protecting group absorbs less atmospheric moisture than its Fmoc cousin, cutting down spoilage risk in humid climates. On the plant floor, our line operators worry less about cross-contamination or bottle-to-bottle migration simply because the dusting and aroma profile don’t linger like some Fmoc derivatives. This matters if you make multi-kilo runs or batch-sequence runs that must remain cross-contamination free.

    Compared to methyl or ethyl-ester versions, the free acid structure of our Boc-Gamma-Abu-OH provides more direct coupling ability. Labs avoid introducing extra hydrolysis or saponification steps, which speeds up multi-step synthesis and increases throughput. Having a non-ester product on hand means chemists can enter their resin loading or solution-phase couplings with greater confidence—and avoid unplanned acid or base treatments known to degrade sensitive sequences.

    From Large-Scale Batches to Early Lab Development

    Routine production lines bring unique challenges, but scaling up Boc-Gamma-Abu-OH tests every stage of process discipline. We have walked through scale-up failures at other plants, tracing yield crashes to crude purification or incomplete deprotection staging. In our experience, sharp attention to temperature gradients during Boc protection, followed by careful crystallization, leads to higher initial yields and less waste downstream. Younger chemists sometimes overlook how crystallization rates impact not just crystal size but long-term stability, both in cold storage and on a dusty shelf. We’ve trained teams to spot minute shifts in appearance, since discolored powder or excessive dust indicates improper aging, which quickly leads to clogs or failing dissolution tests later under real lab conditions.

    Few products reveal the discipline of a chemical plant like Boc-Gamma-Abu-OH. Systematic in-line sampling, real-time pH tracking, and early solvent evaporation checks can pay off. Our technical managers insist on direct analytical checks for every intermediate, using HPLC and mass spectrometry to verify removal of both starting materials and all potential N-protected or O-protected side products. This process isn’t just “quality control” but technical feedback used by production staff to tighten every subsequent batch. Over decades, these steps have condensed the cycle time from raw material to customer-ready product and reduced energy, solvent, and labor costs by a significant proportion.

    Challenges in Modern Synthesis and Customer Solutions

    Customer labs report increased scrutiny around residue solvents and trace metallic contaminants in every supplied amino acid intermediate. Over the years, local and export regulations raised the bar on purity and safety—motivating us to review solvent recovery, wash cycles, and even material-handling logistics. In response, our plants have improved drying chamber design, invested in inert-atmosphere storage, and adopted more comprehensive solvent-testing routines. Our QC teams document each run with sample logs and digital chromatographs, so customers can review, down to the batch, the lineage and test results for every shipment. This level of transparency anchors trust when global supply routes lengthen or when regulations tighten.

    One overlooked factor, especially in larger research programs, relates to batch-to-batch reproducibility. We’ve walked through labs where even small inconsistencies in melting point or moisture content forced extra runs or led to incomplete peptide chains—ruining weeks of work. By guiding our crystallization phase and storage handling with customer feedback, and sending out control samples regularly, we address those issues at their root. Beyond the chemistry, such service differentiates factory output from spot-market intermediates or random generic imports.

    Supply reliability has improved, yet we’ve seen years where upstream shortages of precursor chemicals led to pinch points. By building strategic stocks of both Boc anhydride and all starting amines onsite, we limit our own production delays and pass that resilience along in the form of shipment consistency. Most clients care less about technical minutiae and just want the bottles on time, every time, with the same powder they ordered last time. Within the plant, keeping the skill and training level high avoids slowdowns caused by staff turnover or procedural drift. Field visits and remote support, as well as regular refresher training, keep everyone up to date.

    Environmental and Safety Aspects

    In the early years, older methods caused concerns about solvent waste and gas emissions. Updated reactor setups recycle solvents, lower emissions, and make monitoring easier for environmental officers. Each production step—particularly Boc introduction and acidification—comes with tested containment procedures. The safety margin grows when every operator understands each risk associated with tert-butyl and acid-based reagents.

    A common customer question is about the ecological profile of Boc-Gamma-Abu-OH versus analogues. From firsthand audits and regulatory reporting, our reforms in solvent minimization and neutralization make a substantial difference. We reclaimed and reused a significant portion of washing solvents over five years. Customers seeking green chemistry gains can request extra-clean, low-redidue batches, and for those working under new pharma regulations, we can support documentation with full solvent and impurity records.

    Supporting Both Routine and Advanced Research

    Because we’ve supplied Boc-Gamma-Abu-OH to both leading pharma groups and academic labs, we observe wide variation in usage. Some customers run high-throughput screens, others work with small, iterative fragment assemblies. We maintain flexibility in packaging and shipment, since even simple exposure to damp air shifts powder properties. For fragile new research projects, impurity levels, trace water, and reliable delivery matter as much as technical grade. Our long-term clients rarely struggle with variable couplings or extra purification—simply due to our tight control policies in production and handling. The feedback loop with users drives our internal process innovation.

    Some researchers rotate supply from multiple vendors, tracking success rates for different peptide chains but find measurable differences based on source. Only with factory-direct provenance—including retained samples, batch recertification, and transparent analytical profiles—does the synthetic chemistry run trouble-free through longer, multi-sequence projects. We've responded to this trend by opening our process documents and inviting outside audits, a step not always practiced amongst less-experienced manufacturers.

    Continuous Improvement and Looking Forward

    As demand for functionalized amino acids rises, we’re finding more partners in industry and academia want batch traceability, ongoing quality feedback, and actionable support. Our technical service teams discuss project-specific needs, whether that’s lower particle size fractions or alternate drying levels for solid-phase or solution-phase chemistries. Sometimes, customers running automated peptide synthesizers require more granular control over powder flow and dissolution. By mapping process adjustments to user trends, we keep our factory output closely aligned with practical laboratory realities.

    Some improvements begin at the plant but benefit the customer directly: improved packing materials protect against humidity intrusion, zip-seal liners extend shelf life, and on-demand retesting addresses last-minute project changes. Maintaining flexibility means our operations can quickly pivot based on changes in demand or regulation. R&D investment in reaction monitoring, green chemistry, and analytics enable us to bring each batch a step further from just “specification-compliant” toward purpose-fit for evolving industry expectations.

    After years spent refining both product and process, we appreciate Boc-Gamma-Abu-OH’s role in the synthesis chain. It’s no commodity; its value emerges every time a protein fragment assembles cleanly, or a peptide-based drug candidate clears analytical review on the first try. We encourage researchers and operators to communicate their feedback, since our ongoing improvement comes from paying heed to both successes and failures in the field. By manufacturing directly, we carry the responsibility for every bottle, from raw material sourcing through to shelf stability and real-world application.